NewswireToday - /newswire/ -
St Neots, Cambridgeshire, United Kingdom, 2011/09/01 - The Royal Surrey County Hospital, Guildford, relies on SonoSite’s M-Turbo® point-of-care ultrasound system for diagnosis and treatment in its intensive care unit - SonoSite.com.
Dr Justin KirkBayley, consultant intensivist and anaesthetist, explained: “The Royal Surrey County Hospital is a leading general hospital and specialist tertiary centre for cancer and hepatobiliary and oesophagogastric surgery, and our intensive care unit supports a lot of major surgical work. We had outgrown our previous ultrasound system in terms of the image quality we wanted to achieve, and upgraded to the M-Turbo so that we could broaden our range of ultrasound capabilities, as well as having an instrument suitable for training purposes.”
“The M-Turbo is an asset for diagnosis and treatment purposes, meeting all our needs. We can accommodate several different probes and switch between them at the click of a button. It also allows us to perform echocardiography, offering the image quality that radiologists and cardiologists are used to and eliminating the need to borrow equipment from other departments. The easy to use interface, with its large, clearly labelled buttons, makes the system very, very simple to learn and remember, so the M-Turbo is also an ideal training tool. There is no significant start up time, you can get scans up and running straight away, and the learning curve is very shallow indeed; trainees pick things up very quickly. The M-Turbo’s robustness is equally important, as ITU is a fairly rigorous environment. We have had the M-Turbo since March, and everyone loves it. The quality of the images achievable with it is fantastic, and one almost couldn’t hope for anything better.”
For more information about SonoSite products, please contact:
Alexander House, 40A Wilbury Way, Hitchin SG4 0AP
T +44 (0)1462 444 800, F +44 (0)1462 444 801, E: ukresponse[.]sonosite.com.
SonoSite, Inc. (sonosite.com) is the innovator and world leader in bedside and point-of-care ultrasound and an industry leader in ultra high-frequency micro-ultrasound technology and impedance cardiography equipment. Headquartered near Seattle, the company is represented by fourteen subsidiaries and a global distribution network in over 100 countries. SonoSite’s small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care.
SonoSite, Ltd., a wholly owned subsidiary of SonoSite, Inc. based in Hitchin, Hertfordshire, oversees a direct sales distribution network in the UK and provides sales and marketing support for SonoSite's European offices.